In the originally published article there was an error in Table 1. The reduction in monthly migraine days over 12 weeks versus placebo with quarterly fremanezumab was incorrectly given as “-0.6”; this should read “-3.7”.
Share this Article
Related Content In Headache Disorders
Redefining Expectations for Migraine Prevention
touchREVIEWS in Neurology. 2021;17(Suppl. 1):2–7
Treatment guidelines recommend preventive therapy for migraine, based primarily on the frequency of migraine attacks.1 Migraine-related burden of disease increases with the number of headache days; however, even fewer than 4 headache days per month can result in severe disability in addition to impairment during individual episodes.2,3 The needs of patients with migraine go beyond simply reducing […]
Remote Electrical Neuromodulation for the Acute Treatment of Episodic and Chronic Migraine
touchREVIEWS in Neurology. 2021;17(1):6-10 DOI: https://doi.org/10.17925/USN.2021.17.1.6
Migraine is one of the most prevalent and disabling diseases worldwide, affecting more than one billion people in 2016.1 It is characterized by recurrent headache attacks with nausea/vomiting, photophobia and phonophobia.2 Currently, the first line of acute treatment of migraine is pharmacological; however, pharmacological approaches may be ineffective, poorly tolerated, and need to be limited in use […]
The Italian Chapter of the MOST Project: Specific Changes in the Organization of Headache Centres Can Help Improve the Patient Journey
touchREVIEWS in Neurology. 2021;17(1):48-52 DOI: https://doi.org/10.17925/USN.2021.17.1.48
In 2018, the Global Burden of Disease study placed headache disorders as the second leading cause of years lived with disability.1 As another indicator of its burden, headache was ranked among the leading causes of years lived with disability.1 Given its prevalence and severe symptom burden, headache has a consequential negative impact on the quality of life […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!